8-KThe WireStrategic
Results of Operations · Bylaw Amendment
Filed Jan 12, 2026 · 5mo ago · Accession 0001193125-26-009854
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Definium Therapeutics, Inc.
- Ticker
- DFTX
- CIK
- 1813814
- Form type
- 8-K
- Filing date
- Jan 12, 2026
- Report date
- Jan 9, 2026
- Document
- mnmd-20260109.htm
- Size
- 13.7 MB